News | News By Subject | News by Disease News By Date | Search News

Diabetes, Type 1 (insulin dependent) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Alphabet's Verily, Sanofi (SNY) Launch $500 Million Onduo, Joint Venture to Open New HQ in Kendall Square     9/13/2016
Lexicon Pharma (LXRX) Rockets on Late-Stage Diabetes Drug Data     9/12/2016
Pharmaceutical Trade Groups Highlight Research Benefits in New Ad Campaigns     2/25/2016
FDA Clears Eli Lilly (LLY)'s Diabetes Drug Basaglar     12/17/2015
Novo Nordisk A/S (NVO) Finally Bags Diabetes Drug Tresiba U.S. Approval     9/28/2015
Novartis AG (NVS) Launches New Portfolio Of Affordable Medicines for Poor Countries     9/24/2015
Novo Nordisk A/S (NVO)’s Victoza Beats Sanofi (SNY)’s Lixisenatide in Head-to-Head Study, Company Says     9/17/2015
Google (GOOG)'s Life Sciences to Partner with Sanofi (SNY) on Diabetes Therapies and Monitors     9/1/2015
Novo Nordisk A/S (NVO) Pulls the Plug on Expanding Victoza for Type 1 Diabetes     8/27/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Study Shows Novo Nordisk A/S (NVO)'s New Diabetes Drug Tresiba Effective And Safe For Children     9/16/2014
Bay Area's Hyperion Therapeutics (HPTX) Tanks As Employee Misconduct Leads To Drug Trial Halt     9/10/2014
Eli Lilly and Company (LLY)'s Diabetes Drug Trumps Sanofi (SAN.PA)'s In Phase 3 Trials     9/5/2014

News from Around the Web
Artificial Pancreas Race Intensifies Between These 3 Medtech Firms     11/21/2016
Type 1 Diabetes Linked To Epilepsy Risk, China Medical University Children's Hospital Study     4/1/2016
New Findings Could Boost Type 1 Diabetes Treatment, University of Exeter Study     2/29/2016
Infant Weight Gain Linked To Diabetes Risk, Norwegian Institute Of Public Health Study     12/8/2015
Stuff In Yogurt May Decrease Type 1 Diabetes Risk, University of South Florida     11/12/2015
Kids With Type 1 Diabetes At Risk For Mental Health Problems, Karolinska Institute Reveals     2/19/2015
Novel "Smart" Insulin Can Sense Blood Sugar Levels, University of Utah Study     2/10/2015
Broad Institute Researchers Find Link Between Microbiome, Type 1 Diabetes     2/9/2015
Young Kids With Type 1 Diabetes Have Slower Brain Growth, Nemours Children's Clinic Study     12/22/2014
Popular Blood Pressure Drug May Reverse Type 1 Diabetes, University of Alabama at Birmingham Study     11/12/2014
Gluten-Free Diet Cuts Type 1 Diabetes Risk, University of Copenhagen Study     5/9/2014
Men With Diabetes Have Better Blood Sugar Control Than Women, University of Edinburgh Study     9/24/2013
Diabetes Cases Hit Record and Half Go Undiagnosed, International Diabetes Federation Reveals     11/14/2012
Drug Significantly Improves Glycemic Control in Type 1 Diabetics on Insulin, University at Buffalo Study     6/16/2011
Many Kids with Diabetes Have Other Immune Diseases, University of Colorado Study     4/22/2011

Press Releases
Lexicon Pharma (LXRX) Reports Top-Line Results From Phase 2 Clinical Trial Conducted In Collaboration With Juvenile Diabetes Research Foundation     12/6/2016
Lexicon Pharma (LXRX) Reports Positive Top-Line Results In Phase 2 Dose-Ranging Study For Sotagliflozin In Patients With Type 1 Diabetes     10/25/2016
Johnson & Johnson (JNJ)'s Insulin Pump Vulnerable To Hacking     10/4/2016
Tandem Diabetes Care Now Taking Orders For Next-Generation T:Slim X2 Insulin Pump     10/4/2016
Reimbursement Of DexCom (DXCM) CGM Technology For Patients With Type 1 And Type 2 Insulin-Dependent Diabetes Is Now Available In Germany     9/8/2016
NYU Langone Medical Center Release: Antibiotic Treatment Increased Risk For Type 1 Diabetes In Animal Study     8/22/2016
Merck & Co. (MRK) Announces FDA Filing Acceptance Of New Drug Application (NDA) For MK-1293, An Investigational Follow-On Biologic Insulin Glargine     8/5/2016
Lexicon Pharma (LXRX) Provides Clinical Pipeline Update And Reports 2016 Second Quarter Financial Results     8/4/2016
Innovative Test That Could Predict Risk Of Kidney Failure In Pediatric Type 1 Diabetes Patients Announced At 68th American Association for Clinical Chemistry Annual Scientific Meeting     8/2/2016
Caladrius Biosciences (CLBS) Receives FDA Fast Track Designation For CLBS03 To Treat Recent Onset Type 1 Diabetes     7/28/2016
JDRF Announces Partnership With Arecor Ltd To Support Development Of A Stable, Rapid-Acting, Ultra-Concentrated Insulin     7/25/2016
ViaCyte To Present At ISSCR 2016 Annual Meeting     6/22/2016
Merck & Co. (MRK)’s Investigational Insulin Glargine, MK-1293, Met Primary Endpoint In Two Phase III Studies, Showing Non-Inferiority To Lantus     6/13/2016
Diabetes Research Institute Foundation Release: First Type 1 Diabetes Patient In Europe Is Free From Insulin Therapy After Undergoing Diabetes Research Institute's Biohub Transplant Technique     6/10/2016
Merck & Co. (MRK) To Present Phase III Data On Investigational Medicines Ertugliflozin And MK-1293 At The 76th Scientific Sessions Of The American Diabetes Association     5/12/2016

//-->